The transition from postexposure prophylaxis to preexposure prophylaxis

An emerging opportunity for biobehavioral HIV prevention

Sachin Jain, Douglas S. Krakower, Kenneth H. Mayer

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Although some individuals who present for antiretroviral postexposure prophylaxis (PEP) had a 1-time exposure to human immunodeficiency virus (HIV), others may be recurrently risky. Given that preexposure prophylaxis (PrEP) has been shown to be efficacious, identification of those individuals who present for PEP who might benefit from PrEP is important to decrease HIV acquisition in high-risk individuals. While inclusion criteria for PrEP have been developed, there is a paucity of data to help clinicians determine which PEP users are at highest risk for HIV acquisition and therefore should be offered PrEP. We will discuss the rationale for using PrEP after PEP use, and will focus on the assessment of PEP users who may benefit from PrEP.

Original languageEnglish (US)
Pages (from-to)S200-S204
JournalClinical Infectious Diseases
Volume60
DOIs
StatePublished - 2015

Fingerprint

HIV

Keywords

  • HIV prevention
  • Postexposure prophylaxis
  • Preexposure prophylaxis

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

The transition from postexposure prophylaxis to preexposure prophylaxis : An emerging opportunity for biobehavioral HIV prevention. / Jain, Sachin; Krakower, Douglas S.; Mayer, Kenneth H.

In: Clinical Infectious Diseases, Vol. 60, 2015, p. S200-S204.

Research output: Contribution to journalArticle

@article{68c9a4036ebf47ef8b867b94aca09657,
title = "The transition from postexposure prophylaxis to preexposure prophylaxis: An emerging opportunity for biobehavioral HIV prevention",
abstract = "Although some individuals who present for antiretroviral postexposure prophylaxis (PEP) had a 1-time exposure to human immunodeficiency virus (HIV), others may be recurrently risky. Given that preexposure prophylaxis (PrEP) has been shown to be efficacious, identification of those individuals who present for PEP who might benefit from PrEP is important to decrease HIV acquisition in high-risk individuals. While inclusion criteria for PrEP have been developed, there is a paucity of data to help clinicians determine which PEP users are at highest risk for HIV acquisition and therefore should be offered PrEP. We will discuss the rationale for using PrEP after PEP use, and will focus on the assessment of PEP users who may benefit from PrEP.",
keywords = "HIV prevention, Postexposure prophylaxis, Preexposure prophylaxis",
author = "Sachin Jain and Krakower, {Douglas S.} and Mayer, {Kenneth H.}",
year = "2015",
doi = "10.1093/cid/civ094",
language = "English (US)",
volume = "60",
pages = "S200--S204",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - The transition from postexposure prophylaxis to preexposure prophylaxis

T2 - An emerging opportunity for biobehavioral HIV prevention

AU - Jain, Sachin

AU - Krakower, Douglas S.

AU - Mayer, Kenneth H.

PY - 2015

Y1 - 2015

N2 - Although some individuals who present for antiretroviral postexposure prophylaxis (PEP) had a 1-time exposure to human immunodeficiency virus (HIV), others may be recurrently risky. Given that preexposure prophylaxis (PrEP) has been shown to be efficacious, identification of those individuals who present for PEP who might benefit from PrEP is important to decrease HIV acquisition in high-risk individuals. While inclusion criteria for PrEP have been developed, there is a paucity of data to help clinicians determine which PEP users are at highest risk for HIV acquisition and therefore should be offered PrEP. We will discuss the rationale for using PrEP after PEP use, and will focus on the assessment of PEP users who may benefit from PrEP.

AB - Although some individuals who present for antiretroviral postexposure prophylaxis (PEP) had a 1-time exposure to human immunodeficiency virus (HIV), others may be recurrently risky. Given that preexposure prophylaxis (PrEP) has been shown to be efficacious, identification of those individuals who present for PEP who might benefit from PrEP is important to decrease HIV acquisition in high-risk individuals. While inclusion criteria for PrEP have been developed, there is a paucity of data to help clinicians determine which PEP users are at highest risk for HIV acquisition and therefore should be offered PrEP. We will discuss the rationale for using PrEP after PEP use, and will focus on the assessment of PEP users who may benefit from PrEP.

KW - HIV prevention

KW - Postexposure prophylaxis

KW - Preexposure prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=84942089707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942089707&partnerID=8YFLogxK

U2 - 10.1093/cid/civ094

DO - 10.1093/cid/civ094

M3 - Article

VL - 60

SP - S200-S204

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

ER -